Cyabra was formed to effect itsBusinesscombination and now serves as a publicly traded company. Its fully owned subsidiary, Legacy Cyabra, is an Israeli company formed on July 13, 2017 that works to uncover disinformation.
Cyngn is an autonomous vehicle technology company focused on industrial uses of autonomous vehicles.
Datacentrex describes itself as a diversified technology driven enterprise operating a digital assetMiningbusiness, with plans to move into digital asset infrastructure,Data Centeroperations andQuantum Computingadjacent technologies.
Digital Brands is a curated collection of lifestyle brands, including Bailey 44, DSTLD, Stateside, Sundry and Avo, sold through direct-to-consumer and wholesale distribution.
Elicio is a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers. Its pipeline targets driver tumor mutations using common, well-characterized neoantigens.
On July 17, 2025, the company announced private placements of 44,414,189 shares of common stock and pre-funded warrants for up to 5,728,662 shares at USD 10.00 per share. Aggregate gross proceeds were approximately USD 501.0 million, including USD 28.0 million paid in Bitcoin, and …
The announcement came on the day of the topline readout from the Phase 3 LUCIA study of DURAVYU in wet age related macular degeneration. The study did not meet its primary endpoint of non-inferiority, though the company reported vision improvements. It met key secondary …
Fathom is headquartered in Cary, North Carolina, and describes itself as a national, technology-driven, end-to-end real estate services company integrating residential brokerage, mortgage, title and software.
Fermi says it exists to power the artificial intelligence needs of tomorrow. It is developing a utility-scale private-grid powered campus for AI-centric customers, with grid-independent and interdependent energy generation and high-performance computing facilities built for the hyperscale era.
Filana is a clinical-stage biotechnology company based in Austin, Texas, developing medicines for central nervous system disorders such as Tuberous Sclerosis Complex.